Found 6 matching trials
rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG PHASE1 This is a phase I, open label, plus expansion clinical trial evaluating the...
Show More Location
Children's Health Orange County (CHOC)
Learn More & Join Trial
Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas PHASE2 This is an open-label, non-randomized, single-institution, single arm Phase...
Show More Status
Active Not Recruiting
Location
University of Colorado Hospital
Learn More & Join Trial
A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab PHASE1 The purpose of this Phase 1/2 study is to test the overall safety, tolerabi...
Show More Location
MD Anderson Cancer Center
Learn More & Join Trial
A Phase II Study of Balstilimab Independently or in Combination With Zalifrelimab in Advanced Cervical Cancer PHASE2 This is an open-label, multi-center Phase II clinical trial to assess the e...
Show More Location
Betta Clinical Study Site 4
Learn More & Join Trial
A Study of Zalifrelimab and Balstilimab for Treatment of Participants With Metastatic or Locally Advanced Solid Tumors, and Expansion Into Select Solid Tumors (Cervical) PHASE1 This is a Phase 1/2, open-label study of zalifrelimab (AGEN1884) in combina...
Show More Location
Comprehensive Care and Research Center
Learn More & Join Trial
Expanded Access for Cancer Treatment With Balstilimab (AGEN2034) and Zalifrelimab (AGEN1884) N/A This is an expanded access study for cancer treatment with balstilimab alon...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial